Top

International Urogynecology Journal

Published in:

Open Access 01-05-2019 | Review Article

The use of laser in urogynaecology

Authors: Alka A. Bhide, Vik Khullar, Stephen Swift, Giuseppe A. Digesu

Published in: International Urogynecology Journal | Issue 5/2019

Abstract

Introduction

The use of lasers in urogynaecology has increased in recent years. Their use has been described in pelvic organ prolapse, urinary incontinence and genito-urinary symptoms of menopause. The aim of this study was to review the published literature on CO₂ and erbium:YAG laser use in urogynaecological conditions.

Methods

An extensive search of literature databases (PubMed, EMBASE) was performed for publications (full text and abstracts) written in English up to July 2018. Relevant trials were selected and analysed by an independent reviewer. Twenty-five studies were identified in total.

Results

All studies were either prospective cohort or case-control studies. The results of individual studies indicate that both CO₂ and erbium lasers are effective in treating urogynaecological conditions. Most studies use a vaginal approach with only two investigations of intraurethral application.

Conclusion

The use of lasers to treat these conditions may seem appealing; however, the lack of good-quality evidence in the form of multi-centre randomised placebo-controlled trials is concerning. The safety and effectiveness of these laser devices have not been established. Use of lasers may lead to serious adverse events such as vaginal burns, scarring, dyspareunia and chronic pain. Randomised placebo-controlled trials in addition to formal evaluation of the laser devices are required before this treatment modality can be recommended.

Abrams P, Cardozo L, Khoury S, Wein A. Incontinence: 5th International Consultation on Incontinence. In: Epidemiology of urinary (UI) and faecal (FI) and pelvic organ prolapse (POP). 2012.

O’Dowd TC. Urinary incontinence in women: the management of urinary incontinence in women. Nice Guideline. 2013.

Lee MS. Treatment of vaginal relaxation syndrome with an erbium:YAG laser using 90 degrees and 360 degrees scanning scopes: a pilot study & short-term results. Laser Ther. 2014;23.2:129–38.CrossRef

Portman DJ, Gass MLS, Kingsberg S, Archer D, Bachmann G, Burrows L, et al. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women’s sexual health and the North American Menopause Society. Menopause. 2014;21(10):1063–8.CrossRefPubMed

Gaspar A, Addamo G, Brandi H. Vaginal fractional CO ₂ laser: a minimally invasive option for vaginal rejuvenation. Am J Cosmet Surg. 2011;28(3):156–62.CrossRef

Gambacciani M, Levancini M. Vaginal erbium laser: the second generation thermotherapy for the genitourinary syndrome of menopause (GSM) in breast cancer survivors. A preliminary report of a pilot study. Ital J Gynaecol Obstet. 2015;27:N;1.

Ogrinc UB, Senčar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med. 2015;47(9):689–97.CrossRefPubMedPubMedCentral

Fistonić N, Fistonić I, Guštek ŠF, Turina ISB, Marton I, Vižintin Z, et al. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women—a pilot study. Lasers Med Sci. 2016;31(4):635–43.CrossRefPubMedPubMedCentral

Fistonić N, Fistonić I, Lukanovič A, Findri G, Sorta Bilajac Turina I, Franić D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015;18:37–42.CrossRefPubMed

10.

Pardo JI, Solà VR, Morales AA. Treatment of female stress urinary incontinence with erbium-YAG laser in non-ablative mode. Eur J Obstet Gynecol Reprod Biol. 2016;204:1–4.CrossRefPubMed

11.

Pitsouni E, Grigoriadis T, Tsiveleka A, Zacharakis D, Salvatore S, Athanasiou S. Microablative fractional CO₂-laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas. 2016;94:131–6.CrossRefPubMed

12.

Gaspar A, Brandi H. Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency). Lasers Med Sci. 2017;32(3):685–91.CrossRefPubMed

13.

Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018;21(2):148–52.CrossRefPubMed

14.

Perino A, Cucinella G, Gugliotta G, Saitta S, Polito S, Adile B, et al. Is vaginal fractional CO₂ laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol Sci. 2016;20(12):2491–7.PubMed

15.

Lin Y-H, Hsieh W-C, Huang L, Liang C-C. Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwan J Obstet Gynecol. 2017;56(6):815–20.CrossRefPubMed

16.

Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10–5.CrossRefPubMed

17.

Omi T, Numano K. The role of the CO₂ laser and fractional CO₂ laser in dermatology. LASER Ther. 2014;23(1):49–60.CrossRefPubMedPubMedCentral

18.

Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12-week treatment with fractional CO₂ laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363–9.CrossRefPubMed

19.

Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, et al. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy. Climacteric. 2015;18(2):219–25.CrossRefPubMed

20.

Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO₂ laser. Maturitas. 2015;80(3):296–301.CrossRefPubMed

21.

Sokol ER, Karram MM. An assessment of the safety and efficacy of a fractional CO₂ laser system for the treatment of vulvovaginal atrophy. Menopause. 2016;23(10):1102–7.CrossRefPubMed

22.

Sokol ER, Karram MM. Use of a novel fractional CO₂ laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Menopause. 2017;24(7):810–4.CrossRefPubMed

23.

Behnia-Willison F, Sarraf S, Miller J, Mohamadi B, Care AS, Lam A, et al. Safety and long-term efficacy of fractional CO₂ laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol. 2017;213:39–44.CrossRefPubMed

24.

Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. 2017;49(2):160–8.CrossRefPubMed

25.

Gaspar A, Maestri S, Silva J, Brandi H, Luque D, Koron N, et al. Intraurethral erbium: YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study. Lasers Surg Med. 2018. https://doi.org/10.1002/lsm.22826.

26.

Gambacciani M, Torelli MG, Martella L, Bracco GL, Casagrande AG, Albertin E, et al. Rationale and design for the vaginal erbium laser academy study (Velas): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric. 2015;18(Suppl 1):43–8.CrossRefPubMed

27.

Gaviria JE, Lanz JA. Laser vaginal tightening (LVT) – evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome. J Laser Heal Acad Artic J LAHA. 2012;2012(1):59–66.

28.

Bizjak-Ogrinc U, Sentra S. Non-surgical minimally invasive Er:YAG Laser treatment for higher grade cystocele. Poster 38th IUGA Meeting, Dublin, Ireland. 2013.

29.

Bizjak-Ogrinc U, Sencar S, Vizintin Z. * #178 3 years follow-up of pelvic organ prolapses treated with Er:YAG laser. Lasers Surg Med. 2017;49,issue S28.

30.

Stefano S, Stavros A, Massimo C. The use of pulsed CO₂ lasers for the treatment of vulvovaginal atrophy. Curr Opin Obstet Gynecol. 2015;27:504–8.

Title: The use of laser in urogynaecology
Authors: Alka A. Bhide
Vik Khullar
Stephen Swift
Giuseppe A. Digesu
Publication date: 01-05-2019
Publisher: Springer International Publishing
Published in: International Urogynecology Journal / Issue 5/2019
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-018-3844-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The use of laser in urogynaecology

Abstract

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2019

Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women

Long-term outcomes of anti-incontinence surgery and subsequent transvaginal sling incision for urethral obstruction

Randomized controlled trial of silver-alloy-impregnated suprapubic catheters versus standard suprapubic catheters in assessing urinary tract infection rates in urogynecology patients

Retrospective review of intra- and post-operative complications with minimal versus large space of Retzius infiltration at the time of retropubic TVT placement

Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial

Commentary on “Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women”